Single-dose BNT162b2 vaccine protects against asymptomatic SARS-CoV-2 infection.
Saved in:
| Title: | Single-dose BNT162b2 vaccine protects against asymptomatic SARS-CoV-2 infection. |
|---|---|
| Authors: | Jones NK; Cambridge University NHS Hospitals Foundation Trust, Cambridge, United Kingdom.; Clinical Microbiology & Public Health Laboratory, Public Health England, Cambridge, United Kingdom., Rivett L; Cambridge University NHS Hospitals Foundation Trust, Cambridge, United Kingdom.; Clinical Microbiology & Public Health Laboratory, Public Health England, Cambridge, United Kingdom., Seaman S; Medical Research Council Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom., Samworth RJ; Statistical Laboratory, Centre for Mathematical Sciences, University of Cambridge, Cambridge, United Kingdom., Warne B; Cambridge University NHS Hospitals Foundation Trust, Cambridge, United Kingdom.; Cambridge Institute of Therapeutic Immunology & Infectious Disease, University of Cambridge, Cambridge, United Kingdom.; Department of Medicine, University of Cambridge, Cambridge, United Kingdom., Workman C; Occupational Health and Wellbeing, Cambridge Biomedical Campus, Cambridge, United Kingdom., Ferris M; Occupational Health and Wellbeing, Cambridge Biomedical Campus, Cambridge, United Kingdom., Wright J; Occupational Health and Wellbeing, Cambridge Biomedical Campus, Cambridge, United Kingdom., Quinnell N; Occupational Health and Wellbeing, Cambridge Biomedical Campus, Cambridge, United Kingdom., Shaw A; Cambridge University NHS Hospitals Foundation Trust, Cambridge, United Kingdom., Goodfellow IG; Division of Virology, Department of Pathology, University of Cambridge, Cambridge, United Kingdom., Lehner PJ; Cambridge University NHS Hospitals Foundation Trust, Cambridge, United Kingdom.; Cambridge Institute of Therapeutic Immunology & Infectious Disease, University of Cambridge, Cambridge, United Kingdom.; Department of Medicine, University of Cambridge, Cambridge, United Kingdom., Howes R; Cambridge COVID-19 Testing Centre and AstraZeneca, Anne McLaren Building, Cambridge, United Kingdom., Wright G; Occupational Health and Wellbeing, Cambridge Biomedical Campus, Cambridge, United Kingdom., Matheson NJ; Cambridge University NHS Hospitals Foundation Trust, Cambridge, United Kingdom.; Cambridge Institute of Therapeutic Immunology & Infectious Disease, University of Cambridge, Cambridge, United Kingdom.; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; NHS Blood and Transplant, Cambridge, United Kingdom., Weekes MP; Cambridge University NHS Hospitals Foundation Trust, Cambridge, United Kingdom.; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Cambridge Institute for Medical Research, University of Cambridge, Cambridge, United Kingdom. |
| Corporate Authors: | Cambridge COVID-19 Collaboration; Cambridge University NHS Hospitals Foundation Trust, Cambridge, United Kingdom.; Department of Medicine, University of Cambridge, Cambridge, United Kingdom. |
| Source: | ELife [Elife] 2021 Apr 08; Vol. 10. Date of Electronic Publication: 2021 Apr 08. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: eLife Sciences Publications, Ltd Country of Publication: England NLM ID: 101579614 Publication Model: Electronic Cited Medium: Internet ISSN: 2050-084X (Electronic) Linking ISSN: 2050084X NLM ISO Abbreviation: Elife Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 33830018 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Single-dose BNT162b2 vaccine protects against asymptomatic SARS-CoV-2 infection. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Jones+NK%22">Jones NK</searchLink>; Cambridge University NHS Hospitals Foundation Trust, Cambridge, United Kingdom.; Clinical Microbiology & Public Health Laboratory, Public Health England, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Rivett+L%22">Rivett L</searchLink>; Cambridge University NHS Hospitals Foundation Trust, Cambridge, United Kingdom.; Clinical Microbiology & Public Health Laboratory, Public Health England, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Seaman+S%22">Seaman S</searchLink>; Medical Research Council Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Samworth+RJ%22">Samworth RJ</searchLink>; Statistical Laboratory, Centre for Mathematical Sciences, University of Cambridge, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Warne+B%22">Warne B</searchLink>; Cambridge University NHS Hospitals Foundation Trust, Cambridge, United Kingdom.; Cambridge Institute of Therapeutic Immunology & Infectious Disease, University of Cambridge, Cambridge, United Kingdom.; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Workman+C%22">Workman C</searchLink>; Occupational Health and Wellbeing, Cambridge Biomedical Campus, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Ferris+M%22">Ferris M</searchLink>; Occupational Health and Wellbeing, Cambridge Biomedical Campus, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Wright+J%22">Wright J</searchLink>; Occupational Health and Wellbeing, Cambridge Biomedical Campus, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Quinnell+N%22">Quinnell N</searchLink>; Occupational Health and Wellbeing, Cambridge Biomedical Campus, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Shaw+A%22">Shaw A</searchLink>; Cambridge University NHS Hospitals Foundation Trust, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Goodfellow+IG%22">Goodfellow IG</searchLink>; Division of Virology, Department of Pathology, University of Cambridge, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Lehner+PJ%22">Lehner PJ</searchLink>; Cambridge University NHS Hospitals Foundation Trust, Cambridge, United Kingdom.; Cambridge Institute of Therapeutic Immunology & Infectious Disease, University of Cambridge, Cambridge, United Kingdom.; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Howes+R%22">Howes R</searchLink>; Cambridge COVID-19 Testing Centre and AstraZeneca, Anne McLaren Building, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Wright+G%22">Wright G</searchLink>; Occupational Health and Wellbeing, Cambridge Biomedical Campus, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Matheson+NJ%22">Matheson NJ</searchLink>; Cambridge University NHS Hospitals Foundation Trust, Cambridge, United Kingdom.; Cambridge Institute of Therapeutic Immunology & Infectious Disease, University of Cambridge, Cambridge, United Kingdom.; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; NHS Blood and Transplant, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Weekes+MP%22">Weekes MP</searchLink>; Cambridge University NHS Hospitals Foundation Trust, Cambridge, United Kingdom.; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Cambridge Institute for Medical Research, University of Cambridge, Cambridge, United Kingdom. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22Cambridge+COVID-19+Collaboration%22">Cambridge COVID-19 Collaboration</searchLink>; Cambridge University NHS Hospitals Foundation Trust, Cambridge, United Kingdom.; Department of Medicine, University of Cambridge, Cambridge, United Kingdom. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101579614%22">ELife</searchLink> [Elife] 2021 Apr 08; Vol. 10. <i>Date of Electronic Publication: </i>2021 Apr 08. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22eLife+Sciences+Publications%2C+Ltd%22">eLife Sciences Publications, Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101579614 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2050-084X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222050084X%22">2050084X </searchLink><i>NLM ISO Abbreviation: </i>Elife <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33830018 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.7554/eLife.68808 Languages: – Code: eng Text: English Titles: – TitleFull: Single-dose BNT162b2 vaccine protects against asymptomatic SARS-CoV-2 infection. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Jones NK – PersonEntity: Name: NameFull: Rivett L – PersonEntity: Name: NameFull: Seaman S – PersonEntity: Name: NameFull: Samworth RJ – PersonEntity: Name: NameFull: Warne B – PersonEntity: Name: NameFull: Workman C – PersonEntity: Name: NameFull: Ferris M – PersonEntity: Name: NameFull: Wright J – PersonEntity: Name: NameFull: Quinnell N – PersonEntity: Name: NameFull: Shaw A – PersonEntity: Name: NameFull: Goodfellow IG – PersonEntity: Name: NameFull: Lehner PJ – PersonEntity: Name: NameFull: Howes R – PersonEntity: Name: NameFull: Wright G – PersonEntity: Name: NameFull: Matheson NJ – PersonEntity: Name: NameFull: Weekes MP IsPartOfRelationships: – BibEntity: Dates: – D: 08 M: 04 Text: 2021 Apr 08 Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 2050-084X Numbering: – Type: volume Value: 10 Titles: – TitleFull: ELife Type: main |
| ResultId | 1 |